USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$907.24M
Market Cap
-
P/E Ratio
-2.91
EPS
$23.08
52 Week High
$11.78
52 Week Low
HEALTHCARE
Sector
Field | Value (CHF) |
---|---|
Gross Profit | -$51M |
Total Revenue | $686K |
Cost Of Revenue | $52M |
Costof Goods And Services Sold | $52M |
Operating Income | -$73M |
Selling General And Administrative | $22M |
Research And Development | $52M |
Operating Expenses | $22M |
Investment Income Net | - |
Net Interest Income | $1.5M |
Interest Income | $2.2M |
Interest Expense | $639K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $406K |
Income Before Tax | -$86M |
Income Tax Expense | -$160K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$86M |
Comprehensive Income Net Of Tax | - |
Ebit | -$73M |
Ebitda | -$73M |
Net Income | -$86M |
Field | Value (CHF) |
---|---|
Total Assets | $120M |
Total Current Assets | $105M |
Cash And Cash Equivalents At Carrying Value | $28M |
Cash And Short Term Investments | $28M |
Inventory | - |
Current Net Receivables | $777K |
Total Non Current Assets | $15M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $13M |
Intangible Assets Excluding Goodwill | $13M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $71M |
Other Current Assets | $5.5M |
Other Non Current Assets | - |
Total Liabilities | $47M |
Total Current Liabilities | $44M |
Current Accounts Payable | $5.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $315K |
Total Non Current Liabilities | $2.7M |
Capital Lease Obligations | $1.2M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.2M |
Other Current Liabilities | $38M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $73M |
Treasury Stock | - |
Retained Earnings | -$286M |
Common Stock | $446K |
Common Stock Shares Outstanding | $40M |
Field | Value (CHF) |
---|---|
Operating Cashflow | -$47M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $406K |
Capital Expenditures | $230K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$18M |
Cashflow From Financing | $54M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$86M |
Field | Value (CHF) |
---|---|
Gross Profit | -$51M |
Total Revenue | $686K |
Cost Of Revenue | $52M |
Costof Goods And Services Sold | $52M |
Operating Income | -$73M |
Selling General And Administrative | $22M |
Research And Development | $52M |
Operating Expenses | $22M |
Investment Income Net | - |
Net Interest Income | $1.5M |
Interest Income | $2.2M |
Interest Expense | $639K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $406K |
Income Before Tax | -$86M |
Income Tax Expense | -$160K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$86M |
Comprehensive Income Net Of Tax | - |
Ebit | -$73M |
Ebitda | -$73M |
Net Income | -$86M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company is headquartered in Zug, Switzerland.